These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9023661)

  • 21. In vitro activity of antimicrobial agents against Acinetobacter calcoaceticus.
    Joly-Guillou ML; Bergogne-Berezin E
    Drugs Exp Clin Res; 1986; 12(12):949-52. PubMed ID: 3471431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of antibacterial activities of meropenem and six other antimicrobials against Pseudomonas aeruginosa isolates from North American studies and clinical trials.
    Iaconis JP; Pitkin DH; Sheikh W; Nadler HL
    Clin Infect Dis; 1997 Feb; 24 Suppl 2():S191-6. PubMed ID: 9126693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity of fosfomycin-gentamicin, fosfomycin-ceftazidime, fosfomycin-imipenem and ceftazidime-gentamicin combinations against ceftazidime-resistant Pseudomonas aeruginosa.
    Pruekprasert P; Tunyapanit W
    Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1239-42. PubMed ID: 16438151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of trovafloxacin in combination with ceftazidime, meropenem, and amikacin.
    Milatovic D; Wallrauch C
    Eur J Clin Microbiol Infect Dis; 1996 Aug; 15(8):688-93. PubMed ID: 8894583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of antibiotic synergy against Acinetobacter baumannii: a comparison with Etest, time-kill, and checkerboard methods.
    Bonapace CR; White RL; Friedrich LV; Bosso JA
    Diagn Microbiol Infect Dis; 2000 Sep; 38(1):43-50. PubMed ID: 11025183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of meropenem against ciprofloxacin-resistant enterobacteriaceae and Pseudomonas aeruginosa.
    Garcia-Rodriguez JA; Blazquez AM; Fresnadillo MJ; Garcia Sanchez E; Garcia Sanchez JE; Trujillano Martin I
    J Chemother; 1996 Oct; 8(5):358-64. PubMed ID: 8957715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activities of carbapenems in combination with amikacin, colistin, or fosfomycin against carbapenem-resistant Acinetobacter baumannii clinical isolates.
    Singkham-In U; Chatsuwan T
    Diagn Microbiol Infect Dis; 2018 Jun; 91(2):169-174. PubMed ID: 29433997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quinolone-resistant Salmonella paratyphi B meningitis in a newborn: a case report.
    Bhutta ZA
    J Infect; 1997 Nov; 35(3):308-10. PubMed ID: 9459410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity of fleroxacin and 6 other antimicrobials against Acinetobacter anitratus.
    Kropec A; Daschner F
    Chemotherapy; 1989; 35(5):360-2. PubMed ID: 2507235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
    Zhao C; Xie W; Zhang W; Ye Z; Wu H
    Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program.
    Itokazu GS; Quinn JP; Bell-Dixon C; Kahan FM; Weinstein RA
    Clin Infect Dis; 1996 Oct; 23(4):779-84. PubMed ID: 8909844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between outer membrane protein profiles and resistance to ceftazidime, imipenem, and ciprofloxacin in Pseudomonas aeruginosa isolates from bacteremic patients.
    Gimeno C; Navarro D; Savall F; Millás E; Farga MA; Garau J; Cisterna R; García-de-Lomas J
    Eur J Clin Microbiol Infect Dis; 1996 Jan; 15(1):82-5. PubMed ID: 8641311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postantibiotic effect of imipenem, alone and in combination with amikacin, on Pseudomonas aeruginosa.
    Gerçeker AA; Otük G
    Chemotherapy; 1995; 41(6):433-6. PubMed ID: 8529433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carbapenem-resistant Acinetobacter baumannii: an emerging threat for patients with post-neurosurgical meningitis.
    Metan G; Alp E; Aygen B; Sumerkan B
    Int J Antimicrob Agents; 2007 Jan; 29(1):112-3. PubMed ID: 17134880
    [No Abstract]   [Full Text] [Related]  

  • 35. In vitro activity of ampicillin-sulbactam against clinical multiresistant Acinetobacter baumannii isolates.
    Gales AC; Sader HS; Sinto S; Santos OP; Mendes CM
    J Chemother; 1996 Dec; 8(6):416-9. PubMed ID: 8981180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergy of fosfomycin with other antibiotics for Gram-positive and Gram-negative bacteria.
    Kastoris AC; Rafailidis PI; Vouloumanou EK; Gkegkes ID; Falagas ME
    Eur J Clin Pharmacol; 2010 Apr; 66(4):359-68. PubMed ID: 20186407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activity of levofloxacin and ciprofloxacin in combination with cefepime, ceftazidime, imipenem, piperacillin-tazobactam and amikacin against different Pseudomonas aeruginosa phenotypes and Acinetobacter spp.
    Drago L; De Vecchi E; Nicola L; Colombo A; Guerra A; Gismondo MR
    Chemotherapy; 2004 Oct; 50(4):202-10. PubMed ID: 15452399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antimicrobial susceptibility of Pseudomonas aeruginosa isolated at Kochi Municipal Central Hospital in the last 3 years].
    Nasu Y; Abe M; Ono N; Araki M; Horimi T; Takahashi I
    Jpn J Antibiot; 2004 Oct; 57(5):438-48. PubMed ID: 15655905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends in Drug Resistance of
    Gao L; Lyu Y; Li Y
    Chin Med J (Engl); 2017 Mar; 130(6):659-664. PubMed ID: 28303847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro susceptibility of Acinetobacter baumannii to biapenem, piperacillin/tazobactam and thirteen other antimicrobial agents.
    Simor AE; Louie L; Louie M
    Eur J Clin Microbiol Infect Dis; 1994 Jun; 13(6):521-3. PubMed ID: 7957281
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.